GlassScriptPhysician profile
Aaron D Robinson
NPI 1851666432
$50,828.54
in general payments reported to CMS, 2019-2025
18 companies · $20K in 2025
The $20K reported for 2025 was more than what 98% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $9,290 · 2021: $946 · 2022: $1,850 · 2023: $1,078 · 2024: $900 · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,144 · Travel and Lodging: $4,704 · Honoraria: $4,000 · Food and Beverage: $3,634.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,143.75 |
| Travel and Lodging | $4,703.61 |
| Honoraria | $4,000.00 |
| Food and Beverage | $3,634.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $23,223.85 | 2019-2022 | |
| Inspire Medical Systems, INC. | $21,920.25 | 2021-2025 | Inspire |
| Intersect Ent, INC. | $3,042.46 | 2019-2020 | |
| Genzyme Corporation | $834.27 | 2020-2025 | |
| Regeneron Healthcare Solutions, INC. | $487.23 | 2020-2025 | Dupixent, Libtayo |
| Optinose US, INC. | $303.11 | 2019-2024 | |
| Abbvie INC. | $288.14 | 2021-2025 | Qulipta, Ubrelvy |
| Acclarent, INC | $177.65 | 2019-2024 | Acclarent Aera |
| Medtronic, INC. | $122.41 | 2022 | |
| Smith+Nephew, INC. | $101.99 | 2019-2024 | Rf20000, Tula |
| Glaxosmithkline, LLC. | $80.20 | 2022-2024 | Nucala |
| Access Pro Medical, LLC | $77.77 | 2023 | Matriderm |
| Merck Sharp & Dohme LLC | $52.28 | 2021-2023 | |
| Hologic Sales and Service, LLC | $38.06 | 2024-2025 | Coolseal Generator |
| Alk-Abello, INC | $28.06 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $17.89 | 2020 | |
| Hikma Pharmaceuticals USA | $16.81 | 2024 | Ryaltris |
| Amgen INC. | $16.11 | 2025 | Tezspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Robinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.